ATA268783A - Verfahren zur herstellung von neuen pyridinen und deren aklansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen pyridinen und deren aklansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen

Info

Publication number
ATA268783A
ATA268783A AT0268783A AT268783A ATA268783A AT A268783 A ATA268783 A AT A268783A AT 0268783 A AT0268783 A AT 0268783A AT 268783 A AT268783 A AT 268783A AT A268783 A ATA268783 A AT A268783A
Authority
AT
Austria
Prior art keywords
aclan
pharmaceutically acceptable
addition salts
producing new
methyl ethers
Prior art date
Application number
AT0268783A
Other languages
English (en)
Other versions
AT379801B (de
Inventor
Joseph Georg Lombardino
Charles Armon Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT0268783A priority Critical patent/AT379801B/de
Publication of ATA268783A publication Critical patent/ATA268783A/de
Application granted granted Critical
Publication of AT379801B publication Critical patent/AT379801B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT0268783A 1979-10-15 1983-07-22 Verfahren zur herstellung von neuen pyridinen und deren alkansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen AT379801B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0268783A AT379801B (de) 1979-10-15 1983-07-22 Verfahren zur herstellung von neuen pyridinen und deren alkansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
AT0508980A AT377513B (de) 1979-10-15 1980-10-13 Verfahren zur herstellung von neuen pyridin und pyrimidin-verbindungen und deren salzen
AT0268783A AT379801B (de) 1979-10-15 1983-07-22 Verfahren zur herstellung von neuen pyridinen und deren alkansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen

Publications (2)

Publication Number Publication Date
ATA268783A true ATA268783A (de) 1985-07-15
AT379801B AT379801B (de) 1986-03-10

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0508980A AT377513B (de) 1979-10-15 1980-10-13 Verfahren zur herstellung von neuen pyridin und pyrimidin-verbindungen und deren salzen
AT0268783A AT379801B (de) 1979-10-15 1983-07-22 Verfahren zur herstellung von neuen pyridinen und deren alkansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0508980A AT377513B (de) 1979-10-15 1980-10-13 Verfahren zur herstellung von neuen pyridin und pyrimidin-verbindungen und deren salzen

Country Status (39)

Country Link
US (1) US4246263A (de)
JP (1) JPS5663962A (de)
KR (2) KR840001614B1 (de)
AR (3) AR226864A1 (de)
AT (2) AT377513B (de)
AU (1) AU517763B2 (de)
BE (1) BE885709A (de)
CA (1) CA1156231A (de)
CH (1) CH646425A5 (de)
CS (2) CS226020B2 (de)
DD (2) DD154816B3 (de)
DE (1) DE3038593A1 (de)
DK (1) DK152427C (de)
EG (1) EG14676A (de)
ES (2) ES495932A0 (de)
FI (1) FI75560C (de)
FR (1) FR2467199A1 (de)
GB (2) GB2092133B (de)
GR (1) GR70311B (de)
HK (2) HK1185A (de)
HU (2) HU183233B (de)
IE (1) IE50665B1 (de)
IL (1) IL61261A (de)
IN (2) IN154554B (de)
IT (1) IT1195269B (de)
KE (2) KE3461A (de)
LU (1) LU82844A1 (de)
MY (2) MY8500323A (de)
NL (1) NL8005652A (de)
NO (1) NO156566C (de)
NZ (1) NZ195246A (de)
PH (1) PH18277A (de)
PL (2) PL125314B1 (de)
PT (1) PT71917B (de)
SE (1) SE437023B (de)
SG (2) SG56384G (de)
SU (2) SU1083907A3 (de)
YU (2) YU41740B (de)
ZA (1) ZA806306B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
JPH01502980A (ja) * 1986-06-17 1989-10-12 レイチ，スティーブン　デー ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法
WO2003024955A2 (en) * 2001-09-18 2003-03-27 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
DK1896401T3 (da) * 2005-02-25 2013-06-17 Onconova Therapeutics Inc Syntese af umættede sulfider, sulfoner, sulfoxider og sulfonamider
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
CA3115629A1 (en) 2018-10-08 2020-04-16 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
MY8500323A (en) 1985-12-31
ZA806306B (en) 1981-10-28
AR227576A1 (es) 1982-11-15
FR2467199A1 (fr) 1981-04-17
KR840001614B1 (ko) 1984-10-11
ES8201972A1 (es) 1982-01-16
DK152427C (da) 1988-07-25
GR70311B (de) 1982-09-08
IN154554B (de) 1984-11-10
SU1144617A3 (ru) 1985-03-07
FI803239L (fi) 1981-04-16
IT1195269B (it) 1988-10-12
KR830004263A (ko) 1983-07-09
US4246263A (en) 1981-01-20
DE3038593C2 (de) 1988-11-10
IN163553B (de) 1988-10-08
IT8025324A0 (it) 1980-10-14
FI75560B (fi) 1988-03-31
HU191824B (en) 1987-04-28
KE3466A (en) 1984-11-09
CA1156231A (en) 1983-11-01
AT379801B (de) 1986-03-10
CS226034B2 (en) 1984-03-19
SU1083907A3 (ru) 1984-03-30
AU517763B2 (en) 1981-08-27
NZ195246A (en) 1983-07-15
PH18277A (en) 1985-05-17
PT71917B (en) 1983-01-10
GB2061928A (en) 1981-05-20
IL61261A (en) 1984-08-31
PL227307A1 (de) 1981-11-13
AU6324080A (en) 1981-04-30
CS226020B2 (en) 1984-03-19
ES505544A0 (es) 1982-08-16
IE50665B1 (en) 1986-06-11
EG14676A (en) 1985-03-31
KR840001615B1 (ko) 1984-10-11
GB2061928B (en) 1983-06-02
DD154816A5 (de) 1982-04-21
DE3038593A1 (de) 1981-04-23
YU262680A (en) 1983-09-30
JPS5663962A (en) 1981-05-30
YU266882A (en) 1983-09-30
GB2092133B (en) 1983-03-16
HU183233B (en) 1984-04-28
AR227089A1 (es) 1982-09-15
SE437023B (sv) 1985-02-04
YU42059B (en) 1988-04-30
HK66887A (en) 1987-09-25
NO803073L (no) 1981-04-21
ATA508980A (de) 1984-08-15
MY8500325A (en) 1985-12-31
PT71917A (en) 1980-12-01
ES495932A0 (es) 1982-01-16
JPS6129342B2 (de) 1986-07-05
PL231782A1 (de) 1982-03-01
GB2092133A (en) 1982-08-11
ES8206478A1 (es) 1982-08-16
AR226864A1 (es) 1982-08-31
SG56384G (en) 1985-03-08
BE885709A (fr) 1981-04-14
DK152427B (da) 1988-02-29
FR2467199B1 (de) 1984-12-28
LU82844A1 (fr) 1981-06-04
PL125402B1 (en) 1983-05-31
HK1185A (en) 1985-01-11
DD202543A5 (de) 1983-09-21
IE802125L (en) 1981-04-15
DD154816B3 (de) 1987-05-13
SG69184G (en) 1985-03-15
NO156566B (no) 1987-07-06
NO156566C (no) 1987-10-14
DK403080A (da) 1981-04-16
CH646425A5 (fr) 1984-11-30
KE3461A (en) 1984-10-12
YU41740B (en) 1987-12-31
SE8007193L (sv) 1981-04-16
NL8005652A (nl) 1981-04-21
PL125314B1 (en) 1983-04-30
FI75560C (fi) 1988-07-11
IL61261A0 (en) 1980-12-31
AT377513B (de) 1985-03-25

Similar Documents

Publication Publication Date Title
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
AT362347B (de) Verfahren zur herstellung von neuen 3-phenoxy-3 -phenylpropanaminen sowie deren saeureadditions- salzen
AT359523B (de) Verfahren zur herstellung von neuen 6-amino- alkylaminouracilen sowie deren saeureadditions- salzen
AT361480B (de) Verfahren zur herstellung von neuen amino- alkoxyphenyl-derivaten und deren physiologisch vertraeglichen saeureadditionssalzen
ATA268783A (de) Verfahren zur herstellung von neuen pyridinen und deren aklansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen
AT359186B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen sowie deren pharmazeutisch anwendbaren salzen
AT368490B (de) Verfahren zur herstellung von neuen alkylthio-phenoxy-alkylaminen sowie von deren saeureadditionssalzen
ATA392484A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydrothiazolo(5,4-c)pyridinderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
AT374177B (de) Verfahren zur herstellung von neuen 1-substituierten-3-cycloalkylsulfonyl-pyrrolidi -2,5-dion-derivaten sowie von deren salzen
AT361904B (de) Verfahren zur herstellung von neuen 3-anilino- aethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen
AT353960B (de) Verfahren zur herstellung von neuen bis-peni- cillanoyloxy-alkanen und deren pharmazeutisch annehmbaren salzen
AT347921B (de) Verfahren zur herstellung von neuen 3- (4'-p- halogenphenoxyphenyl)-2-buten-1-olen und -butan-1-olen sowie deren alkansaeureestern
AT359482B (de) Verfahren zur herstellung von neuen hydroxy- aethyliden-cyanessigsaeure-aniliden sowie von deren physiologisch vertraeglichen salzen
AT376438B (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
AT375344B (de) Verfahren zur herstellung von neuen transdecahydrochinolinderivaten und ihren pharmazeutisch annehmbaren saeureadditionssalzen
AT375932B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
ATA247380A (de) Verfahren zur herstellung von neuen, 3-substituierten 2-oxo-hexahydro-pyrimido (1,2-a)azepinen sowie von deren pharmazeutisch geeigneten salzen
ATA333583A (de) Verfahren zur herstellung von neuen indolizinderivaten und deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA333483A (de) Verfahren zur herstellung von neuen indolizinderivaten und deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA104980A (de) Verfahren zur herstellung von 4-(n-hexadecylamino)benzoesaeure und deren pharmazeutisch annehmbaren salzen
ATA257383A (de) Verfahren zur herstellung von neuen 1-substituierten-3-cycloalkylsulfonyl-pyrrolidi -2,5-dion-derivaten sowie von deren salzen
ATA257483A (de) Verfahren zur herstellung von neuen 1-substituierten-3-cycloalkylsulfonyl-pyrrolidi -2,5-dion-derivaten sowie von deren salzen
AT358561B (de) Verfahren zur herstellung von neuen hydroxy- aethyliden-cyanessigsaeure-aniliden sowie von deren physiologisch vertraeglichen salzen
AT358564B (de) Verfahren zur herstellung von neuen hydroxy- aethyliden-cyanessigsaeure-aniliden sowie von deren physiologisch vertraeglichen salzen
AT358562B (de) Verfahren zur herstellung von neuen hydroxy- aethyliden-cyanessigsaeure-aniliden sowie von deren physiologisch vertraeglichen salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties